HemaSphere
(Aug 2023)
PB2297: PHASE II STUDY OF BORTEZOMIB, CYTARABINE, AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MANTLE CELL LYMPHOMA
- Junghoon Shin,
- Ji Yun Lee,
- Gyeong-Won Lee,
- Won Seog Kim,
- Yong Park,
- Young Rok Do,
- Dae Sik Kim,
- Ki Hwan Kim,
- Yoon Seok Choi,
- Youngil Koh
Affiliations
- Junghoon Shin
- 1 Seoul National University Hospital, Korea, Rep. of South
- Ji Yun Lee
- 2 Seoul National University Bundang Hospital, Seongnam-si, Korea, Rep. of South
- Gyeong-Won Lee
- 3 Gyeongsang National University Hospital, Jinju, Korea, Rep. of South
- Won Seog Kim
- 4 Samsung Medical Center, Korea, Rep. of South
- Yong Park
- 5 Korea University Anam Hospital, Korea, Rep. of South
- Young Rok Do
- 6 Keimyung University Dongsan Hospital, Korea, Rep. of South
- Dae Sik Kim
- 7 Korea University Guro Hospital, Korea, Rep. of South
- Ki Hwan Kim
- 8 보라매병원, Korea, Rep. of South
- Yoon Seok Choi
- 9 Chungnam National University Hospital, Korea, Rep. of South
- Youngil Koh
- 1 Seoul National University Hospital, Korea, Rep. of South
- DOI
-
https://doi.org/10.1097/01.HS9.0000975916.71832.73
- Journal volume & issue
-
Vol. 7
p.
e7183273
WeChat QR code